Publication | Open Access

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

OncologyOpen-label Phase 3Cancer ManagementPathologyCancer TreatmentMedicineRadiation OncologyCancer ResearchMolecular OncologyAdvanced Oesophagogastric Cancer